In the world’s first clinical trial for coronavirus antibodies at Yerushalayim’s Hadassah hospital, three patients in moderate condition were released within days after receiving antibodies culled from recovered patients. Much of the blood plasma used to produce the drug was donated by hundreds of chareidi patients.
Israel’s Sheba Medical Center in Ramat Gan has tested an ashtray-sized gadget designed by the Newsight imaging company on 400 people with 95 percent accuracy. By analyzing the light-spectrum of patients’ saliva, the apparatus can detect the molecular signature of the disease within one second. The PCR (polymerase chain reaction)-based molecular tests used currently requires lengthy lab analysis and is only 80 percent accurate.
After collecting 20,000 voice recordings of corona patients in India, Israeli engineers are working on a way to detect the disease by miniscule changes in patients’ voices. Israeli intelligence reports that dogs of the Ukatz canine division have displayed an ability to detect the virus in samples of body fluids.
In Motza near Yerushalayim, the Yvel jewelry company is crafting a $1.5 million diamond-studded gold face mask for a Chinese businessman living in the US who stipulated that it must be the priciest in the world.
“Money maybe doesn’t buy everything, but if it can buy a very expensive Covid-19 mask,” said Yitzchok Levy, owner of the company.